arrow
J

John Devin Peipert

University of Birmingham
H指数:31
被引数:3,533

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Recommendations for the use of clinical outcome assessments in rare disease drug development

罕见病药物开发中临床结局评估的应用建议

2026-07-200
OAAI
Impact of patient-reported taxane-induced peripheral neuropathy on dose reductions or worsening quality of life in Black women with breast cancer: Analysis from ECOG-ACRIN EAZ171

黑种人乳腺癌患者报告的紫杉烷类诱导周围神经病变对剂量减少或生活质量恶化的影响:ECOG-ACRIN EAZ171研究分析

Cancer
IF5.1
2026-05-290
OAAI
Overall side-effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatments

总体不良反应困扰与四项涉及不同癌症类型和治疗方案的临床试验中因不良事件导致的早期治疗中断存在一致关联。

Cancer
IF5.1
2025-10-220
OAAI
HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN THE PHASE 2 FIREFLY-1 (PNOC026) TRIAL OF THE TYPE II RAF INHIBITOR TOVORAFENIB IN RELAPSED/REFRACTORY (R/R) PEDIATRIC LOW-GRADE GLIOMA (PLGG)
2024-11-110
PRE
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable

推进以患者为中心的护理: 在早期临床试验中整合患者报告的结果进行耐受性评估-来自专家虚拟圆桌会议的见解

2024-10-010
OAAI